NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.690
-0.0098 (-1.40%)
At Close: Apr 26, 2024
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)
07:37pm, Thursday, 09'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)
Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY), SAGE Therapeutics (NASDAQ: SAGE) and Pfenex (NYSE MKT: PFNX)
07:37pm, Thursday, 09'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (
INCY
–
Research Report
), SAGE Therapeutics (
SAGE
–
Research Report
) and Pfenex (
PFNX
�
56 Stocks Moving In Tuesday's Mid-Day Session
04:47pm, Tuesday, 07'th Apr 2020
Gainers
Borr Drilling, Inc. (NYSE: BORR) shares jumped 70.9% to $1.3499 after surging over 37% on Monday.
Sasol Limited (NYSE: SSL) shares surged 63.4% to $4.15 amid hopes of...
Goldman Sachs Group Inc. Acquires 20,589 Shares of Atara Biotherapeutics Inc (NASDAQ:ATRA)
09:58am, Tuesday, 07'th Apr 2020
Goldman Sachs Group Inc. grew its holdings in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 5.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 422,532 shares of the biotechnology co
Assembly Biosciences (ASMB) Receives a Buy from Mizuho Securities
05:46pm, Monday, 06'th Apr 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Assembly Biosciences (ASMB), with a price target of $30.00. The
Assembly Biosciences (ASMB) Receives a Buy from Mizuho Securities
05:46pm, Monday, 06'th Apr 2020
In a report released today,
Salim Syed
from Mizuho Securities maintained a
Buy
rating on Assembly Biosciences (
ASMB
–
Research Report
), with a price target of
$30.00
. The company’s shares close
eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications
12:00pm, Monday, 06'th Apr 2020
NEW YORK & CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of safe and effective human-com
Victory Capital Management Inc. Boosts Stock Position in Atara Biotherapeutics Inc (NASDAQ:ATRA)
11:20am, Monday, 06'th Apr 2020
Victory Capital Management Inc. increased its stake in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) by 31.3% in the fourth quarter, according to the company in its most recent 13F filing with the
Canaccord Genuity Thinks Aileron Therapeutics' Stock is Going to Recover
10:12am, Friday, 03'rd Apr 2020
Aileron Therapeutics (ALRN) received a Buy rating and a $5.00 price target from Canaccord Genuity analyst John Newman yesterday. The company's shares
Canaccord Genuity Thinks Aileron Therapeutics’ Stock is Going to Recover
10:12am, Friday, 03'rd Apr 2020
Aileron Therapeutics (ALRN – Research Report) received a Buy rating and a $5.00 price target from Canaccord Genuity analyst John
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Misonix (MSON) and BioNTech SE (BNTX)
10:11am, Friday, 03'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics (ATRA), Misonix (MSON) and BioNTech
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics
